InspireMD to Showcase Innovations at Virtual Healthcare Event

GEEKOM Raises the Bar with A5 2027 Build Every once in a blue moon, a piece of tech pricks up my ears and this time it's the GEEKOM A5 2027 Edition. Released on September 7, 2026, this contraption's not just joining the ranks—it's looking to redefine them. It's geared for the real-world junkie who’s raking through browser tabs, dropping into video meetings, and making...

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

When you dive into the world of laboratory glassware, it might look like it's all pipettes and test tubes, but there's more bubbling under the surface. This market's got its eyes on a neat little climb from $7,630 million in 2026 to a forecasted $9,170 million by 2031. Ain't just speculation—this one's solid muscle growing at a comfortable 4.0% compound annual growth...

California's Election Integrity: A Ticking Time Bomb Strap in for a bumpy ride, folks—California might soon find its electoral process caught in a Washington whirlwind. CalExitNow, the group advocating for California's independence, is sounding alarms about looming federal interventions that could shake the state's democratic foundations. The Federal Storm Rolling In...

Universal's Encore Performance in the Markets Universal Music Group (EURONEXT: UMG), the behemoth in music-based entertainment, just wrapped up its €250 million share buyback program. Talk about a grand finale! In a week’s worth of maneuvering from August 31 to September 4, they snagged 294,340 of their own shares, all for the pretty price of €14.65 a pop. Grand...

An Intriguing Move For Baidu's Class A Shares Well, here we go again, folks. Another move on the chessboard for Baidu. They've just walked their Class A ordinary shares onto the Shenzhen-Hong Kong and Shanghai-Hong Kong Stock Connects. As of today, September 7, 2026, mainland investors can now get their mitts on these shares more easily. It might not be a...

Sustainability Triumph for Ping An: A+ Upgrade Ping An Insurance (Group) Company of China, Ltd. is having quite the moment, snagging an A+ in the latest 2026 Sustainability Rating from Hang Seng Indexes Company. This ain't just a one-time pat on the back—it's the third year of consecutive improvement. Looks like Ping An's focus on ESG efforts is finally getting the...

Withings Joins Forces with French Basketball Elite When it comes to linking technology and sports, nothing quite shows promise like Withings teaming up with the French Basketball Federation (FFBB). Picture this: a French startup that's crafted its legacy on cutting-edge health tech now throws its lot in with a nation proud of its basketball prowess. It's the kind of...

There's a buzz in the air that's hard to ignore—Regan Hutsell from Texas secured the legendary Miss America crown. This event isn't just another chapter in the pageant's nearly century-old saga, but it's a spotlight moment that nods to Miss America's long-enduring cultural resonance. Now, you might be wondering: With all eyes on this Texan, what ripples could she send...

Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...

Tevogen Bio Champions Long COVID Patient Advocacy Tevogen Bio, a clinical-stage biotech company specializing in immunotherapy, is drawing attention for its proactive stance on important healthcare challenges. Recently, the company has turned its focus to advocating for patients with Long COVID. This initiative gained prominence when Tevogen's leadership met with members...

Rybelsus® Shows Significant Reduction in Cardiovascular Events Recent findings from the SOUL cardiovascular outcomes trial have highlighted the effectiveness of Rybelsus® (oral semaglutide) in significantly reducing the risk of major adverse cardiovascular events (MACE) among adults suffering from type 2 diabetes and associated conditions. Clinical data from the trial...

Quipt Home Medical's Strong Start to Fiscal Year 2025 Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT), a prominent provider of home medical equipment with a focus on respiratory care, shared its financial results for the first quarter of fiscal year 2025, covering the three-month period ending December 31, 2024. Diligently reported in U.S. Dollars, these results...

Argent BioPharma's Successful Capital Raise and Future Prospects Argent BioPharma Limited (ASX: RGT) is a clinical-stage biopharmaceutical company that focuses on developing innovative treatments for central nervous system (CNS) and immune-related disorders through advanced nano-medicine technology and neuro-immune modulation. Recently, Argent BioPharma announced a...

Bernie Sanders Criticizes High Costs of Ozempic Senator Bernie Sanders has recently expressed his deep frustration over the soaring prices of Ozempic, a medication made by Novo Nordisk A/S (NYSE: NVO). While it’s primarily prescribed for managing diabetes, Ozempic has also become popular as a weight loss solution. Inconsistent Medication Prices In a fervent post on...